Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

FDG PET: Elevated Plasma Glucose Reduces Both Uptake and Detection Rate of Pancreatic Malignancies

Christoph G. Diederichs, Ludger Staib, Gerhard Glatting, Hans Günther Beger and Sven Norbert Reske
Journal of Nuclear Medicine June 1998, 39 (6) 1030-1033;
Christoph G. Diederichs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludger Staib
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Glatting
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Günther Beger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Norbert Reske
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 6
June 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG PET: Elevated Plasma Glucose Reduces Both Uptake and Detection Rate of Pancreatic Malignancies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDG PET: Elevated Plasma Glucose Reduces Both Uptake and Detection Rate of Pancreatic Malignancies
Christoph G. Diederichs, Ludger Staib, Gerhard Glatting, Hans Günther Beger, Sven Norbert Reske
Journal of Nuclear Medicine Jun 1998, 39 (6) 1030-1033;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDG PET: Elevated Plasma Glucose Reduces Both Uptake and Detection Rate of Pancreatic Malignancies
Christoph G. Diederichs, Ludger Staib, Gerhard Glatting, Hans Günther Beger, Sven Norbert Reske
Journal of Nuclear Medicine Jun 1998, 39 (6) 1030-1033;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
  • Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer
  • Positron Emission Tomography/Computed Tomography for Diagnosis of Prosthetic Valve Endocarditis: Suggestions to Increase Diagnostic Accuracy
  • Clinical Utility of 18F-FDG Positron Emission Tomography and Computed Tomography in Patients With Suspected Cardiovascular Implantable Electronic Device Infection
  • In Vivo SPECT Imaging with 111In-DOTA-c(RGDfK) to Detect Early Pancreatic Cancer in a Hamster Pancreatic Carcinogenesis Model
  • Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments
  • Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis
  • Measuring Response with FDG-PET: Methodological Aspects
  • Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
  • In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors
  • Prosthetic Vascular Graft Infection: The Role of 18F-FDG PET/CT
  • 18F-FDG PET and PET/CT in Fever of Unknown Origin
  • Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
  • The Diabetic Foot: Initial Experience with 18F-FDG PET/CT
  • Respiratory Gating for 3-Dimensional PET of the Thorax: Feasibility and Initial Results
  • 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
  • Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
  • Ki-67 Immunostaining in Pancreatic Cancer and Chronic Active Pancreatitis: Does In Vivo FDG Uptake Correlate with Proliferative Activity?
  • Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
  • Google Scholar

More in this TOC Section

  • Fluorine-18-Fluorodeoxyglucose PET Identification of Cardiac Metastasis Arising from Uterine Cervical Carcinoma
  • PET Evaluation of Therapeutic Limb Perfusion in Merkel's Cell Carcinoma
  • Response to Treatment with Yttrium 90-DOTA-Lanreotide of a Patient with Metastatic Gastrinoma
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire